Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Otto

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Studies in Health Technology and Informatics|September 5, 2024
A Concept for Mining Transitive Sequential Patterns from Pancreatic Cancer Patient JourneysJonas Hügel, Jan Janosch Schneider, Daniel Tran Ortega, et al.
Orthopaedic Journal of Sports Medicine|February 4, 2020
Biomechanical Comparison of Anterograde and Retrograde Lesser Trochanter Avulsion RepairAlexander Otto, Joshua B Baldino, Alyssa M DiCosmo, et al.
Nature Communications|February 24, 2024
Reducing the metabolic burden of rRNA synthesis promotes healthy longevity in Caenorhabditis elegansSamim Sharifi, Prerana Chaudhari, Asya Martirosyan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2021
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212)Dominik Paul Modest, Meinolf Karthaus, Stefan Fruehauf, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2023
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trialAlexej Ballhausen, Meinolf Karthaus, Stefan Fruehauf, et al.
Nature Cell Biology|August 3, 2019
IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastomaSatoshi Kofuji, Akiyoshi Hirayama, Alexander Otto Eberhardt, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Studies in Health Technology and Informatics|September 5, 2024
A Concept for Mining Transitive Sequential Patterns from Pancreatic Cancer Patient JourneysJonas Hügel, Jan Janosch Schneider, Daniel Tran Ortega, et al.
Orthopaedic Journal of Sports Medicine|February 4, 2020
Biomechanical Comparison of Anterograde and Retrograde Lesser Trochanter Avulsion RepairAlexander Otto, Joshua B Baldino, Alyssa M DiCosmo, et al.
Nature Communications|February 24, 2024
Reducing the metabolic burden of rRNA synthesis promotes healthy longevity in Caenorhabditis elegansSamim Sharifi, Prerana Chaudhari, Asya Martirosyan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2021
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212)Dominik Paul Modest, Meinolf Karthaus, Stefan Fruehauf, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2023
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trialAlexej Ballhausen, Meinolf Karthaus, Stefan Fruehauf, et al.
Nature Cell Biology|August 3, 2019
IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastomaSatoshi Kofuji, Akiyoshi Hirayama, Alexander Otto Eberhardt, et al.
Pageof 6